Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose This study aimed to determine the incidence of male breast cancer (MBC) and its survival outcomes in Korea, and to compare these results to those for female breast cancer (FBC). Materials and Methods We searched the Korea Central Cancer Registry and identified 227,122 breast cancer cases that were diagnosed between 1999 and 2016. Demographic and clinical characteristics and overall survival (OS) rates were estimated according to sex, age, histological type, and cancer stage. Results The 227,122 patients included 1,094 MBC cases and 226,028 FBC cases. Based on the age-standardized rate, the male: female ratio was 0.0055:1. The most common ages at diagnosis were 60-69 years for MBC and 40-49 years for FBC (p < 0.001). Male patients were less likely than female patients to receive adjuvant radiotherapy (7.5% vs. 21.8%, p < 0.001) or adjuvant chemotherapy (40.1% vs. 55.4%, p < 0.001). The 5-year OS rates after diagnosis were 88.8% for all patients, although it was significantly lower for MBC than for FBC (76.2% vs. 88.9%, p < 0.001). In both groups, older age (! 60 years) was associated with shorter survival. The 5-year OS rates for the invasive histological types were 75.8% for men and 89.0% for women. The 5-year OS rates in both groups decreased with increasing cancer stage. Conclusion MBC was diagnosed at older ages than FBC, and male patients were less likely to receive radiotherapy and chemotherapy. The survival outcomes were worse for MBC than for FBC, with even poorer outcomes related to older age, the inflammatory histological types, and advanced stage. It is important that clinicians recognize the differences between FBC and MBC when treating these patients.
Abstract
Purpose This study aimed to determine the incidence of male breast cancer (MBC) and its survival outcomes in Korea, and to compare these results to those for female breast cancer (FBC). Materials and Methods We searched the Korea Central Cancer Registry and identified 227,122 breast cancer cases that were diagnosed between 1999 and 2016. Demographic and clinical characteristics and overall survival (OS) rates were estimated according to sex, age, histological type, and cancer stage. Results The 227,122 patients included 1,094 MBC cases and 226,028 FBC cases. Based on the age-standardized rate, the male: female ratio was 0.0055:1. The most common ages at diagnosis were 60-69 years for MBC and 40-49 years for FBC (p < 0.001). Male patients were less likely than female patients to receive adjuvant radiotherapy (7.5% vs. 21.8%, p < 0.001) or adjuvant chemotherapy (40.1% vs. 55.4%, p < 0.001). The 5-year OS rates after diagnosis were 88.8% for all patients, although it was significantly lower for MBC than for FBC (76.2% vs. 88.9%, p < 0.001). In both groups, older age (! 60 years) was associated with shorter survival. The 5-year OS rates for the invasive histological types were 75.8% for men and 89.0% for women. The 5-year OS rates in both groups decreased with increasing cancer stage. Conclusion MBC was diagnosed at older ages than FBC, and male patients were less likely to receive radiotherapy and chemotherapy. The survival outcomes were worse for MBC than for FBC, with even poorer outcomes related to older age, the inflammatory histological types, and advanced stage. It is important that clinicians recognize the differences between FBC and MBC when treating these patients.
참고문헌 (30)
- Jemal A, "Cancer statistics, 2010", CA Cancer J Clin, 60, pp.277~300 (2010)
- Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- Giordano SH, "Breast carcinoma in men : a population-based study", Cancer, 101, pp.51~57 (2004)
- 홍지형, "Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 Years", Cancer Research and Treatment, 48(4), pp.1389~1398 (2016), 대한암학회
- Anderson WF, "Male breast cancer : a population-based comparison with female breast cancer", J Clin Oncol, 28, pp.232~239 (2010)
- Liu N, "Male breast cancer : an updated Surveillance, Epidemiology, and End Results data analysis", Clin Breast Cancer, 18, pp.e997~e1002 (2018)
- Gomez-Raposo C, "Male breast cancer", Cancer Treat Rev, 36, pp.451~457 (2010)
- World Health Organization, "International statistical classification of diseases and related health problems", World Health Organization, ~ (1994)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- Statistical methods in cancer research. Volume IV. Descriptive epidemiology, "Esteve J", IARC, 1~302, pp.IARC Sci Publ. (128) (1994)
- Hill TD, "Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival", Ann Epidemiol, 15, pp.773~780 (2005)
- White J, "Male breast carcinoma : increased awareness needed", Breast Cancer Res, 13, pp.219~ (2011)
- Ioka A, "Survival of male breast cancer patients : a population-based study in Osaka, Japan", Jpn J Clin Oncol, 36, pp.699~703 (2006)
- Giordano SH, "A review of the diagnosis and management of male breast cancer", Oncologist, 10, pp.471~479 (2005)
- Miao H, "Incidence and outcome of male breast cancer : an international population-based study", J Clin Oncol, 29, pp.4381~4386 (2011)
- Giordano SH, "Breast cancer in men", Ann Intern Med, 137, pp.678~687 (2002)
- Choi MY, "Characterization of Korean male breast cancer using an online nationwide breast-cancer database : matched-pair analysis of patients with female breast cancer", Medicine(Baltimore), 95, pp.e3299~ (2016)
- Fentiman IS, "Male breast cancer", Lancet, 367, pp.595~604 (2006)
- Erlichman C, "Male breast cancer : a 13-year review of 89 patients", J Clin Oncol, 2, pp.903~909 (1984)
- Gough DB, "A 50-year experience of male breast cancer : is outcome changing", Surg Oncol, 2, pp.325~333 (1993)
- Chakravarthy A, "Post-mastectomy radiation in male breast cancer", Radiother Oncol, 65, pp.99~103 (2002)
- Yu E, "The impact of post-mastectomy radiation therapy on male breast cancer patients : a case series", Int J Radiat Oncol Biol Phys, 82, pp.696~700 (2012)
- Jung SY, "Different patterns of conditional survival of breast cancer patients by age and histologic types : evidence from the Korean nationwide registry", Cancer Epidemiol Biomarkers Prev, 28, pp.1169~1176 (2019)
- Gnerlich JL, "Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration", Ann Surg Oncol, 18, pp.1837~1844 (2011)
- Scott-Conner CE, "An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients", Surgery, 126, pp.775~780 (1999)
- Marchal F, "Men with breast cancer have same disease-specific and event-free survival as women", Ann Surg Oncol, 16, pp.972~978 (2009)
- Bharat A, "Patient and tumor characteristics associated with increased mortality in young women(< or =40 years)with breast cancer", J Surg Oncol, 100, pp.248~251 (2009)
- Gnerlich JL, "Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease", J Am Coll Surg, 208, pp.341~347 (2009)
- Berglund A, "Impact of comorbidity on management and mortality in women diagnosed with breast cancer", Breast Cancer Res Treat, 135, pp.281~289 (2012)
- Mohamad HB, "Counseling for male BRCA mutation carriers : a review", Breast, 17, pp.441~450 (2008)